Exome sequencing for diagnosis of congenital hemolytic anemia.
Anemia
Congenital
Hemolysis
Membrane
Mutation
NGS
Red blood cell
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
08 07 2020
08 07 2020
Historique:
received:
20
02
2020
accepted:
27
05
2020
entrez:
10
7
2020
pubmed:
10
7
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Congenital hemolytic anemia constitutes a heterogeneous group of rare genetic disorders of red blood cells. Diagnosis is based on clinical data, family history and phenotypic testing, genetic analyses being usually performed as a late step. In this study, we explored 40 patients with congenital hemolytic anemia by whole exome sequencing: 20 patients with hereditary spherocytosis and 20 patients with unexplained hemolysis. A probable genetic cause of disease was identified in 82.5% of the patients (33/40): 100% of those with suspected hereditary spherocytosis (20/20) and 65% of those with unexplained hemolysis (13/20). We found that several patients carried genetic variations in more than one gene (3/20 in the hereditary spherocytosis group, 6/13 fully elucidated patients in the unexplained hemolysis group), giving a more accurate picture of the genetic complexity of congenital hemolytic anemia. In addition, whole exome sequencing allowed us to identify genetic variants in non-congenital hemolytic anemia genes that explained part of the phenotype in 3 patients. The rapid development of next generation sequencing has rendered the genetic study of these diseases much easier and cheaper. Whole exome sequencing in congenital hemolytic anemia could provide a more precise and quicker diagnosis, improve patients' healthcare and probably has to be democratized notably for complex cases.
Sections du résumé
BACKGROUND
Congenital hemolytic anemia constitutes a heterogeneous group of rare genetic disorders of red blood cells. Diagnosis is based on clinical data, family history and phenotypic testing, genetic analyses being usually performed as a late step. In this study, we explored 40 patients with congenital hemolytic anemia by whole exome sequencing: 20 patients with hereditary spherocytosis and 20 patients with unexplained hemolysis.
RESULTS
A probable genetic cause of disease was identified in 82.5% of the patients (33/40): 100% of those with suspected hereditary spherocytosis (20/20) and 65% of those with unexplained hemolysis (13/20). We found that several patients carried genetic variations in more than one gene (3/20 in the hereditary spherocytosis group, 6/13 fully elucidated patients in the unexplained hemolysis group), giving a more accurate picture of the genetic complexity of congenital hemolytic anemia. In addition, whole exome sequencing allowed us to identify genetic variants in non-congenital hemolytic anemia genes that explained part of the phenotype in 3 patients.
CONCLUSION
The rapid development of next generation sequencing has rendered the genetic study of these diseases much easier and cheaper. Whole exome sequencing in congenital hemolytic anemia could provide a more precise and quicker diagnosis, improve patients' healthcare and probably has to be democratized notably for complex cases.
Identifiants
pubmed: 32641076
doi: 10.1186/s13023-020-01425-5
pii: 10.1186/s13023-020-01425-5
pmc: PMC7341591
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
180Références
Blood Cells Mol Dis. 2017 May;64:38-44
pubmed: 28376382
Br J Haematol. 2004 Oct;127(1):118-22
pubmed: 15384986
Science. 2000 Dec 1;290(5497):1765-8
pubmed: 11099415
Cold Spring Harb Mol Case Stud. 2016 Jul;2(4):a000885
pubmed: 27551681
Blood. 2003 Jul 15;102(2):698-704
pubmed: 12663458
Can J Gastroenterol Hepatol. 2014 Apr;28(4):198-202
pubmed: 24729993
Circ Cardiovasc Genet. 2017 Feb;10(1):
pubmed: 28087566
J Clin Invest. 2019 Apr 30;129(7):2878-2887
pubmed: 31038472
J Am Soc Nephrol. 2010 May;21(5):859-67
pubmed: 20203157
Blood. 1998 Dec 1;92(11):4481-2
pubmed: 9882098
Neonatology. 2014;105(1):1-4
pubmed: 24193021
Neuron. 2006 Dec 7;52(5):767-74
pubmed: 17145499
Int J Lab Hematol. 2016 Dec;38(6):629-638
pubmed: 27427187
Physiol Rev. 2016 Jul;96(3):911-73
pubmed: 27252279
Cytometry B Clin Cytom. 2008 Jul;74(4):244-50
pubmed: 18454487
Mol Immunol. 2015 Jun;65(2):367-76
pubmed: 25733390
Br J Haematol. 1996 Oct;95(1):57-66
pubmed: 8857939
Blood. 2008 Nov 15;112(10):3939-48
pubmed: 18988878
Blood. 2010 Aug 12;116(6):988-92
pubmed: 20404132
Br J Haematol. 2019 May;185(3):578-582
pubmed: 30198572
Haematologica. 2016 Nov;101(11):1284-1294
pubmed: 27756835
Blood Cells Mol Dis. 2016 Oct;61:4-9
pubmed: 27667160
Bone Marrow Transplant. 2016 Dec;51(12):1605-1608
pubmed: 27595284
Blood. 1994 Oct 15;84(8):2823-4
pubmed: 7919393
Haematologica. 2019 Aug;104(8):1554-1564
pubmed: 30655378
Eur J Dermatol. 2017 Oct 1;27(5):519-523
pubmed: 28739549
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10717-22
pubmed: 10485892
Hematology Am Soc Hematol Educ Program. 2015;2015:392-9
pubmed: 26637748
Gene. 2017 Sep 5;627:556-562
pubmed: 28694211
Genet Med. 2018 Jun;20(6):645-654
pubmed: 29095811
Blood. 2012 Oct 11;120(15):3136-41
pubmed: 22919030
J Med Genet. 2016 Oct;53(10):705-9
pubmed: 27330106
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5171-5
pubmed: 3393536
Int J Hematol. 2018 Sep;108(3):306-311
pubmed: 29936674
Int J Lab Hematol. 2015 Jun;37(3):304-25
pubmed: 25790109
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Hum Mol Genet. 2014 Oct 1;23(19):5283-93
pubmed: 24847005
Br J Haematol. 2008 Feb;140(4):468-70
pubmed: 18162119
Eur J Haematol. 2018 Sep;101(3):368-378
pubmed: 29901818
Am J Hum Genet. 2017 Feb 2;100(2):267-280
pubmed: 28132688
Blood Adv. 2018 Oct 23;2(20):2646-2657
pubmed: 30327373
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Eur J Haematol. 2018 Sep;101(3):297-304
pubmed: 29786897
Br J Haematol. 1995 May;90(1):71-6
pubmed: 7786798
Hemoglobin. 2009;33(6):475-9
pubmed: 19958192
J Clin Pathol. 2019 Jan;72(1):81-85
pubmed: 30337328
Blood Res. 2017 Jun;52(2):84-94
pubmed: 28698843
Sci China Life Sci. 2018 Aug;61(8):947-953
pubmed: 29572776
Neuropediatrics. 2017 Jun;48(3):166-184
pubmed: 28561207
EMBO Rep. 2013 Feb;14(2):152-63
pubmed: 23306656
Expert Rev Hematol. 2016 Mar;9(3):283-96
pubmed: 26653117
Semin Hematol. 2004 Apr;41(2):142-64
pubmed: 15071791
Hematology Am Soc Hematol Educ Program. 2005;:19-23
pubmed: 16304354
Br J Haematol. 2016 Sep;174(5):806-14
pubmed: 27292444
Lancet. 2008 Oct 18;372(9647):1411-26
pubmed: 18940465
Br J Haematol. 2016 Oct;175(2):318-330
pubmed: 27432187
Exp Hematol. 2016 Oct;44(10):947-63
pubmed: 27373493
Am J Hematol. 2019 Jan;94(1):149-161
pubmed: 30358897
J Pediatr Hematol Oncol. 2018 Oct;40(7):e421-e423
pubmed: 29846281
Cell. 2018 Apr 5;173(2):443-455.e12
pubmed: 29576450
Clin Chim Acta. 2018 Dec;487:311-317
pubmed: 30317022
Kidney Int. 2012 Aug;82(4):454-64
pubmed: 22456601
Haematologica. 2012 Dec;97(12):1786-94
pubmed: 23065504
PLoS One. 2015 Jun 24;10(6):e0131251
pubmed: 26107955
Database (Oxford). 2015 Jun 14;2015:bav056
pubmed: 26078478
Clin Exp Dermatol. 2016 Dec;41(8):933-934
pubmed: 27747905
Am J Med Genet A. 2017 Nov;173(11):3087-3092
pubmed: 28898540
Ann Hematol. 2016 Dec;95(12):2043-2048
pubmed: 27553379
Pediatr Clin North Am. 2013 Dec;60(6):1349-62
pubmed: 24237975
Int J Lab Hematol. 2019 May;41 Suppl 1:95-101
pubmed: 31069991
Cold Spring Harb Mol Case Stud. 2018 Oct 1;4(5):
pubmed: 30275003
Biochim Biophys Acta. 2014 May;1844(5):1003-10
pubmed: 24129076
Am J Hematol. 2018 May;93(5):672-682
pubmed: 29396846